TheraSphere for the Treatment of Liver Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Interventions
DEVICE

Yttrium 90 glass microspheres

120 Gy unilobar or bilobar infusion with the second infusion occurring 3-7 weeks following treatment of the first lobe

Trial Locations (5)

12208

Albany Medical Center, Albany

53226

Medical College of Wisconsin, Froedtert Hospital, Milwaukee

55905

Mayo Clinic, Rochester

60611-2927

Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center, Chicago

21287-4010

John Hopkins Hospital, Baltimore

Sponsors
All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Boston Scientific Corporation

INDUSTRY

NCT00511862 - TheraSphere for the Treatment of Liver Metastases | Biotech Hunter | Biotech Hunter